Table 4.

List of antibodies the level (from protein arrays) of which at the time of transplant and 6 months post-transplant correlates with CAI progression in the future

Gene SymbolAntigen NameSpearman Correlation (r)P Value
Antibody level measured at the time of transplantation correlates with 6-mo chronic injury
 GABPAGA binding protein transcription factor, α subunit0.464.31E−02
 MIGChemokine (C-X-C motif) ligand 90.742.00E−04
 ITACChemokine (C-X-C motif) ligand 110.492.90E−02
 IFNGIFN-γ 0.605.50E−03
 GDNFGlial cell-derived neurotrophic factor0.551.12E−02
Antibody level measured at the time of transplantation correlates with 24-mo chronic injury
 IL-8IL-80.463.98E−02
 CCL21Chemokine (C-C motif) ligand 210.492.94E−02
 MIGChemokine (C-X-C motif) ligand0.715.00E−04
 ITACChemokine (C-X-C motif) ligand 110.541.36E−02
 IFNGIFN-γ0.733.00E−04
 GDNFGlial cell-derived neurotrophic factor0.623.20E−03
Antibody level measured at 6 mo post-transplantation correlates with 24-mo chronic injury
 IL-8IL-80.473.87E−02
 MIGChemokine (C-X-C motif) ligand 90.464.25E−02
 IL21IL-210.512.16E−02
 CCL19Chemokine (C-C motif) ligand 190.483.30E−02
 LRRK2Leucine-rich repeat kinase0.464.25E−02
 CCL21Chemokine (C-C motif) ligand 210.473.77E−02
 GDNFGlial cell-derived neurotrophic factor0.605.30E−03
 IFNGIFN-γ0.596.30E−03